These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31359238)

  • 21. Predictors of poor glycaemic control during the initial five years post-diagnosis in rural adults with type 2 diabetes.
    Kellow NJ; Savige GS; Khalil H
    Aust J Rural Health; 2011 Oct; 19(5):267-74. PubMed ID: 21933370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial.
    Agarwal P; Mukerji G; Desveaux L; Ivers NM; Bhattacharyya O; Hensel JM; Shaw J; Bouck Z; Jamieson T; Onabajo N; Cooper M; Marani H; Jeffs L; Bhatia RS
    JMIR Mhealth Uhealth; 2019 Jan; 7(1):e10321. PubMed ID: 30632972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus.
    Al Mazroui NR; Kamal MM; Ghabash NM; Yacout TA; Kole PL; McElnay JC
    Br J Clin Pharmacol; 2009 May; 67(5):547-57. PubMed ID: 19552750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biophysiologic outcomes of the Enhancing Adherence in Type 2 Diabetes (ENHANCE) trial.
    Sevick MA; Korytkowski M; Stone RA; Piraino B; Ren D; Sereika S; Wang Y; Steenkiste A; Burke LE
    J Acad Nutr Diet; 2012 Aug; 112(8):1147-57. PubMed ID: 22818724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes - a nationwide cross-sectional study.
    Svedbo Engström M; Leksell J; Johansson UB; Borg S; Palaszewski B; Franzén S; Gudbjörnsdottir S; Eeg-Olofsson K
    Health Qual Life Outcomes; 2019 Aug; 17(1):141. PubMed ID: 31412881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-perception of health status, mental health and quality of life among adults with diabetes residing in a metropolitan area.
    Esteban y Peña MM; Hernandez Barrera V; Fernández Cordero X; Gil de Miguel A; Rodríguez Pérez M; Lopez-de Andres A; Jiménez-García R
    Diabetes Metab; 2010 Sep; 36(4):305-11. PubMed ID: 20483647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial.
    Wishah RA; Al-Khawaldeh OA; Albsoul AM
    Diabetes Metab Syndr; 2015; 9(4):271-6. PubMed ID: 25301007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifestyle changes and glycemic control in type 1 diabetes mellitus: a trial protocol with factorial design approach.
    Sawani S; Siddiqui AR; Azam SI; Humayun K; Ahmed A; Habib A; Naz S; Tufail M; Iqbal R
    Trials; 2020 Apr; 21(1):346. PubMed ID: 32312302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in depressive symptoms and glycemic control in diabetes mellitus.
    Georgiades A; Zucker N; Friedman KE; Mosunic CJ; Applegate K; Lane JD; Feinglos MN; Surwit RS
    Psychosom Med; 2007 Apr; 69(3):235-41. PubMed ID: 17420441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How different domains of quality of life are associated with latent dimensions of mental health measured by GHQ-12.
    Nouri F; Feizi A; Roohafza H; Sadeghi M; Sarrafzadegan N
    Health Qual Life Outcomes; 2021 Nov; 19(1):255. PubMed ID: 34775961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of diabetes indices of care by a short pharmaceutical care program.
    Turnacilar M; Sancar M; Apikoglu-Rabus S; Hursitoglu M; Izzettin FV
    Pharm World Sci; 2009 Dec; 31(6):689-95. PubMed ID: 19777365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
    Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
    J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    Johansen MY; MacDonald CS; Hansen KB; Karstoft K; Christensen R; Pedersen M; Hansen LS; Zacho M; Wedell-Neergaard AS; Nielsen ST; Iepsen UW; Langberg H; Vaag AA; Pedersen BK; Ried-Larsen M
    JAMA; 2017 Aug; 318(7):637-646. PubMed ID: 28810024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of lifestyle education program for type 2 diabetes patients in clinics: a cluster randomized controlled trial.
    Adachi M; Yamaoka K; Watanabe M; Nishikawa M; Kobayashi I; Hida E; Tango T
    BMC Public Health; 2013 May; 13():467. PubMed ID: 23672733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized study of two different target levels of glycemic control within the acceptable range in type 2 diabetes. Effects on well-being at 1 year.
    van der Does FE; de Neeling JN; Snoek FJ; Grootenhuis PA; Kostense PJ; Bouter LM; Heine RJ
    Diabetes Care; 1998 Dec; 21(12):2085-93. PubMed ID: 9839098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus.
    Raval AD; Nguyen MH; Zhou S; Grabner M; Barron J; Quimbo R
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1111-1123. PubMed ID: 31556817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
    Chung N; Rascati K; Lopez D; Jokerst J; Garza A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of physician's diabetes self-management education using Japan Association of Diabetes Education and Care Diabetes Education Card System Program and a self-monitoring of blood glucose readings analyzer in individuals with type 2 diabetes: An exploratory, open-labeled, prospective randomized clinical trial.
    Tanaka N; Yabe D; Murotani K; Yamaguchi Y; Fujita Y; Kubota S; Nakashima-Yasuda R; Kubota-Okamoto S; Ueno S; Yamazaki Y; Kuwata H; Watanabe K; Hyo T; Hamamoto Y; Kurose T; Higashiyama H; Seino Y; Yamada Y; Seino Y
    J Diabetes Investig; 2021 Dec; 12(12):2221-2231. PubMed ID: 34087060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
    Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
    Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China.
    Bi Y; Zhu D; Cheng J; Zhu Y; Xu N; Cui S; Li W; Cheng X; Wang F; Hu Y; Shen S; Weng J
    Clin Ther; 2010 May; 32(5):973-83. PubMed ID: 20685506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.